Not yet recruitingPhase 2NCT07293403
Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
Studying Nodal T-follicular helper cell lymphoma, follicular type
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- City of Hope Medical Center
- Principal Investigator
- Christina Poh, M.DCity of Hope Medical Center
- Intervention
- Biospecimen Collection(procedure)
- Enrollment
- 25 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- City of Hope Medical Center, Duarte, California, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07293403 on ClinicalTrials.govOther trials for Nodal T-follicular helper cell lymphoma, follicular type
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06347653Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)Peking University
- RECRUITINGPHASE1, PHASE2NCT05230680Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS)Won Seog Kim
See all trials for Nodal T-follicular helper cell lymphoma, follicular type →